The study investigates the prevalence and duration of taste and smell changes in young testicular cancer patients undergoing cisplatin-based chemotherapy. Given the high incidence of these sensory alterations, which can lead to malnutrition and unhealthy eating patterns, there is a significant market opportunity for nutritional interventions and oral nutrition supplements (ONS) tailored for this demographic. The findings may inform product development strategies for supportive care in oncology, particularly in addressing the nutritional needs of cancer survivors. The competitive landscape includes existing nutritional products but may lack targeted solutions for this specific patient population, presenting a potential niche market. Diligence should focus on the integration of study findings into product claims and marketing strategies to enhance patient adherence and outcomes.